Similar Posts
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Survey Reveals Orphan Drugs Companies are Hindered by Internal Limitations
Orphan drugs encounter challenges that extend from their initial discovery to eventual launch, primarily due to the restricted patient numbers and niche…
PBPK Modelling: Optimizing Controlled Release Dosage Form Development
Creating controlled release drugs, which release medicine at a specific rate or location in the digestive system, can be difficult. Physiologically-based pharmacokinetic…
The Role of Roller Compaction in Dose Design
Introduction: Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes. It offers better overall stability…
Customer Requirements for Oral Dose Development
Pharmaceutical developers aim for cost-effective oral medications that work well. This can be challenging, requiring an understanding of client, patient, and provider…
Techniques for Choosing and Developing a Drug Candidate
Employing information regarding an active pharmaceutical ingredient’s physicochemical characteristics obtained from pre-formulation and formulation investigations enhances the probability of achieving success in…
